PHASE-II PILOT-STUDY OF CAELYX (DOXORUBICIN HCI, PEGYLATED LIPOSOMAL)IN PATIENTS WITH INOPERABLE SQUAMOUS-CELL CANCER OF THE HEAD AND NECK

Authors
HARRINGTON KJ HARRISON D STEWART JSW
Citation
Kj. Harrington et al., PHASE-II PILOT-STUDY OF CAELYX (DOXORUBICIN HCI, PEGYLATED LIPOSOMAL)IN PATIENTS WITH INOPERABLE SQUAMOUS-CELL CANCER OF THE HEAD AND NECK, European journal of cancer, 34, 1998, pp. 150-150
Citations number
NO
Categorie Soggetti
Oncology
Journal title
European journal of cancer → ACNP
ISSN journal
09598049
Volume
34
Year of publication
1998
Supplement
2
Pages
150 - 150
Database
ISI
SICI code
0959-8049(1998)34:<150:PPOC(H>2.0.ZU;2-1